| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Blanck Ronald R is a Director at TENX. Recent filings cover 5 purchases and 1 sale. Those positions are worth an estimated $6K at current prices.
Blanck Ronald R's largest disclosed position is in TENX as Director, worth about $6K. Net of sales, the recent Form 4 record there shows accumulation of 8,900 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 18, 2020 | TENX Tenax Therapeutics, Inc. | Director | Buy | 5,000 | $0.95 | $4,774.00 | +470.8% | |
| Dec 18, 2017 | TENX Tenax Therapeutics, Inc. | Director | Buy | 12,950 | $0.45 | $5,887.07 | +181.1% | |
| Nov 14, 2017 | TENX Tenax Therapeutics, Inc. | Director | Sell | 12,950 | $0.39 | $5,050.50 | -64.4% | |
| Nov 19, 2015 | TENX Tenax Therapeutics, Inc. | Director | Buy | 1,900 | $3.20 | $6,080.00 | +14.7% | |
| Jan 20, 2015 | TENX Tenax Therapeutics, Inc. | Director | Buy | 2,000 | $3.49 | $6,980.00 | +24.4% |